chr16-1510955-C-CT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_014714.4(IFT140):βc.4377_4378insAβ(p.Asp1460ArgfsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,611,612 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000039 ( 0 hom., cov: 33)
Exomes π: 0.0000014 ( 0 hom. )
Consequence
IFT140
NM_014714.4 frameshift
NM_014714.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.60
Genes affected
IFT140 (HGNC:29077): (intraflagellar transport 140) This gene encodes one of the subunits of the intraflagellar transport (IFT) complex A. Intraflagellar transport is involved in the genesis, resorption and signaling of primary cilia. The primary cilium is a microtubule-based sensory organelle at the surface of most quiescent mammalian cells, that receives signals from its environment, such as the flow of fluid, light or odors, and transduces those signals to the nucleus. Loss of the corresponding protein in mouse results in renal cystic disease. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Frameshift in the end of transcript resulting in stoplost. Downstream stopcodon found after 1601 codons.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFT140 | NM_014714.4 | c.4377_4378insA | p.Asp1460ArgfsTer60 | frameshift_variant | 31/31 | ENST00000426508.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFT140 | ENST00000426508.7 | c.4377_4378insA | p.Asp1460ArgfsTer60 | frameshift_variant | 31/31 | 5 | NM_014714.4 | P1 | |
IFT140 | ENST00000361339.9 | c.1959_1960insA | p.Asp654ArgfsTer60 | frameshift_variant | 13/13 | 1 | |||
IFT140 | ENST00000565298.5 | n.4201_4202insA | non_coding_transcript_exon_variant | 19/19 | 2 | ||||
IFT140 | ENST00000397417.6 | c.*2815_*2816insA | 3_prime_UTR_variant, NMD_transcript_variant | 24/24 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152260Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152260
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000811 AC: 2AN: 246458Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133702
GnomAD3 exomes
AF:
AC:
2
AN:
246458
Hom.:
AF XY:
AC XY:
0
AN XY:
133702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459352Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 725780
GnomAD4 exome
AF:
AC:
2
AN:
1459352
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
725780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384
GnomAD4 genome
AF:
AC:
6
AN:
152260
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Saldino-Mainzer syndrome;C4540439:Retinitis pigmentosa 80 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 11, 2022 | - - |
Saldino-Mainzer syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 05, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1449015). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. This variant is present in population databases (rs753109181, gnomAD 0.01%). This sequence change results in a frameshift in the IFT140 gene (p.Asp1460Argfs*60). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 3 amino acid(s) of the IFT140 protein and extend the protein by 56 additional amino acid residues. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at